Research ArticleOriginal Article
Open Access

Prevalence of transfusion-transmitted infections in Saudi Arabia blood donors

A nationwide, cross-sectional study

Jawaher Alsughayyir, Yasser Almalki, Imtinan Alburayk, Mohrah Alalshaik, Ibrahim Aljoni, Mona Kandel, Mohammad A. Alfhili and Abdulmajeed A. Alabdullateef
Saudi Medical Journal December 2022, 43 (12) 1363-1372; DOI: https://doi.org/10.15537/smj.2022.43.12.20220634

References

  1. 1.↵
    1. Kogutt BK,
    2. Vaught AJ.
    Postpartum hemorrhage: Blood product management and massive transfusion. Semin Perinatol 2019; 43: 44–50.
    OpenUrlPubMed
  2. 2.↵
    1. Villanueva C.
    Gastrointestinal bleeding: Blood transfusion for acute upper gastrointestinal bleeding. Nat Rev Gastroenterol Hepatol 2015; 12: 432–424.
    OpenUrl
  3. 3.↵
    1. Alkhamis A.
    Health care system in Saudi Arabia: an overview. East Mediterr Health J 2012; 18: 1078–1079.
    OpenUrl
  4. 4.↵
    1. Alsughayyir J,
    2. Almalki Y,
    3. Alalshaik M,
    4. Aljoni I,
    5. Taha M,
    6. Alfhili M, et al.
    Blood donation rate and blood product wastage in Saudi Arabia: A nationwide retrospective study. Saudi J Biol Sci 2022; 29: 103450.
    OpenUrl
  5. 5.↵
    World Health Organization. Global Status Report on Blood Safety and Availability. [Updated 2016; Accessed 2020 Apr 15]. Available from: https://apps.who.int/iris/bitstream/handle/10665/254987/9789241565431-eng.pdf
  6. 6.↵
    Ministry of Health. Press Report on MOHs Efforts Regarding Blood Donation. [Updated 2013. Accessed 2022 April 20].
  7. 7.↵
    1. Rahman R.
    The Privatization of Health Care System in Saudi Arabia. Health Serv Insights. 2020;13:1178632920934497.
    OpenUrlPubMed
  8. 8.↵
    1. Simon MS,
    2. Leff JA,
    3. Pandya A,
    4. Cushing M,
    5. Shaz BH,
    6. Calfee DP, et al.
    Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. Transfusion (Paris) 2014; 54: 889–899.
    OpenUrlCrossRef
  9. 9.↵
    1. Alabdulmonem W,
    2. Shariq A,
    3. Alqossayir F,
    4. AbaAlkhail FM,
    5. Al-Musallam AY,
    6. Alzaaqi FO
    , et al. Sero-prevalence ABO and Rh blood groups and their associated transfusion-transmissible infections among blood donors in the Central Region of Saudi Arabia. J Infect Public Health 2020; 13: 299–305.
    OpenUrl
  10. 10.
    1. Alqahtani SM,
    2. A Alsagaby S,
    3. Mir SA,
    4. Alaidarous M,
    5. Bin Dukhyil A,
    6. Alshehri B
    , et al. Seroprevalence of viral hepatitis B and C among blood donors in the Northern Region of Riyadh Province, Saudi Arabia. Healthcare (Basel) 2021; 9: 934–945.
    OpenUrl
  11. 11.
    1. Hindawi S,
    2. Badawi M,
    3. Fouda F,
    4. Mallah B,
    5. Mallah B,
    6. Rajab H, et al.
    Testing for HTLV 1 and HTLV 2 among blood donors in Western Saudi Arabia: prevalence and cost considerations. Transfus Med 2018; 28: 60–64.
    OpenUrl
  12. 12.
    1. El-Taher SM,
    2. Fouad NA,
    3. Fouad MA,
    4. Mahedy AW,
    5. Elnazi AK.
    Transfusion-transmitted virus infection in hemodialysis patients in Arar, Saudi Arabia: Prevalence, predictors and genotyping. Saudi J Kidney Dis Transpl 2015; 26: 1215–1222.
    OpenUrl
  13. 13.↵
    1. Chaabna K,
    2. Cheema S,
    3. Abraham A,
    4. Alrouh H,
    5. Lowenfels AB,
    6. Maisonneuve P, et al.
    Systematic overview of hepatitis C infection in the Middle East and North Africa. World J Gastroenterol 2018; 24: 3038.
    OpenUrl
  14. 14.↵
    Food and Drug Administration. Donor Screening Assays. [Updated 2022 Jul 15: Accessed 2022 March 15].
  15. 15.↵
    1. Lv LS,
    2. Jin DH,
    3. Ma WJ,
    4. Liu T,
    5. Xu YQ,
    6. Zhang XE, et al.
    The impact of non-optimum ambient temperature on years of life Lost: A multi-county observational study in Hunan, China. Int J Environ Res Public Health 2020; 17: 2699.
    OpenUrl
  16. 16.↵
    1. Meyer D,
    2. Zeileis A,
    3. Hornik K.
    The Strucplot Framework: Visualizing Multi-way Contingency Tables with vcd. J Stat Softw 2006; 17.
  17. 17.↵
    1. Farshadpour F,
    2. Taherkhani R,
    3. Tajbakhsh S,
    4. Gholizadeh Tangestani M,
    5. Hajiani G,
    6. Sharifi N, et al.
    Prevalence and trends of transfusion-transmissible viral infections among blood donors in South of Iran: An eleven-year retrospective study. PLoS One 2016; 11: e0157615.
    OpenUrl
  18. 18.↵
    1. Souan L,
    2. Tout F,
    3. Siag M,
    4. Sughayer MA.
    Seroprevalence rates of transfusion-transmitted infections among blood donors in Jordan. J Infect Dev Ctries 2016; 10: 377–383.
    OpenUrlCrossRef
  19. 19.↵
    World Health Organization (WHO). Global Status Report on Blood Safety and Availability. [Updated 2016; accessed 2022 April 14].
  20. 20.↵
    Centers for Disease Control and Prevention. Hepatitis B - Chapter 4-2020 Yellow Book, Travelers’ Health. [Updated 2020; Accessed 2022 April 20]. Available from: https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/hepatitis-B#5514
  21. 21.↵
    1. Alshayea AI,
    2. Eid GE,
    3. El-Hazmi MM,
    4. Alhetheel AF.
    Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia. Saudi Med J 2016; 37: 1114–1119.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Abdo AA,
    2. Sanai FM,
    3. Al-Faleh FZ.
    Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook? Saudi J Gastroenterol 2012; 18: 349–357.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. AlAteeq MA,
    2. AlEnazi LM,
    3. AlShammari MS,
    4. AlAnazi EE,
    5. Al-Hababi FH,
    6. Alateeq AM.
    Long-term immunity against hepatitis B virus after routine immunization among adults visiting primary care centers in Riyadh, Saudi Arabia. Cureus 2022; 14: e21266.
    OpenUrl
  24. 24.↵
    1. Arif M,
    2. Ramia S,
    3. al-Rashed R
    1. al-Jeffry M
    1. al-Faleh FZ,
    2. Ayoola EA
    , Arif M, Ramia S, al-Rashed R, al-Jeffry M, et al. Seroepidemiology of hepatitis B virus infection in Saudi Arabian children: a baseline survey for mass vaccination against hepatitis B. J Infect 1992; 24: 197–206.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Fiedler SA,
    2. Oberle D,
    3. Chudy M,
    4. Scheiblauer H,
    5. Henseler O,
    6. Halbauer J, et al.
    Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015). Vox Sang 2019; 114: 443–450.
    OpenUrl
  26. 26.↵
    1. Candotti D,
    2. Laperche S.
    Hepatitis B virus blood screening: need for reappraisal of blood safety measures? Front Med (Lausanne) 2018; 5: 29.
    OpenUrl
  27. 27.↵
    1. Raimondo G,
    2. Locarnini S,
    3. Pollicino T,
    4. Levrero M,
    5. Zoulim F,
    6. Lok AS, et al.
    Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol 2019; 71: 397–408.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Aljumah AA,
    2. Babatin M,
    3. Hashim A,
    4. Abaalkhail F,
    5. Bassil N,
    6. Safwat M, et al.
    Hepatitis B care pathway in Saudi Arabia: Current situation, gaps and actions. Saudi J Gastroenterol 2019; 25: 73–80.
    OpenUrlPubMed
  29. 29.↵
    Prevention C for DC and. Hepatitis C - Chapter 4-2020 Yellow Book, Travelers’ Health, CDC. Yellow Book. [Updated 2020; Accessed 2022 Jun 18]. Available from: https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/hepatitis-c#5521. Accessed 20 April 2022
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords